Translational Genomics Research Institute
35
2
3
23
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
22.9%
8 terminated/withdrawn out of 35 trials
74.2%
-12.3% vs industry average
0%
0 trials in Phase 3/4
35%
8 of 23 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (35)
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
Role: collaborator
Early Onset Alzheimer's Disease Genomic Study
Role: collaborator
Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
Role: collaborator
Molecular-Guided Therapy for Childhood Cancer
Role: collaborator
Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH
Role: collaborator
Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache
Role: collaborator
Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Role: collaborator
Study of Radiation Exposure and Bilateral Breast Cancer
Role: collaborator
Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer
Role: collaborator
Identification of Genomic Changes in Families Having Multiple Members With Tumors
Role: collaborator
Identification of Novel Molecular Markers for Vasospasm
Role: collaborator
Oxytocin for Oxidative Stress and Inflammation
Role: collaborator
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
Role: collaborator
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)
Role: collaborator
Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma
Role: collaborator
Studies in Patients With Tuberous Sclerosis Complex
Role: lead
Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer
Role: collaborator
A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer
Role: collaborator
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
Role: collaborator
A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer
Role: lead